SCHEDULE 13G/A: Deerfield Entities Amend Ventyx Biosciences Stake, Disclosing 0.76% Passive Ownership

Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Partners, L.P., and James E. Flynn have filed an amended Schedule 13G, reporting a combined beneficial ownership of 0.76% in Ventyx Biosciences, Inc. as of December 31, 2024.

Summary

• The filing is an Amendment No. 2 to Schedule 13G for Ventyx Biosciences, Inc. (CUSIP: 92332V107).
• The reporting persons are Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Partners, L.P., and James E. Flynn.
• As of December 31, 2024, the reporting persons collectively beneficially own 534,737 shares of Ventyx Biosciences, Inc. Common Stock.
• This represents 0.76% of the class of securities.
• All reporting persons have shared voting power and shared dispositive power over the 534,737 shares.
• The reporting persons certify that the securities were not acquired or held for the purpose of changing or influencing the control of the issuer.
• Due to their relationships, the reporting persons may be deemed to constitute a group for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934.

Sentiment

Score: 5

Explanation: The filing is a routine disclosure of beneficial ownership and does not contain information that would significantly alter the company's outlook or financial position. It indicates a passive investment.

Positives

• Continued investment by Deerfield entities, indicating ongoing confidence in Ventyx Biosciences, Inc. as a passive investor.

Future Outlook

NA

Management Comments

• The reporting persons certify that the securities referred to were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.

Industry Context

NA

Stakeholder Impact

• Shareholders: Provides transparency on institutional ownership, confirming a passive stake by Deerfield entities.

Key Dates

Keywords

Ventyx Biosciences, Schedule 13G, Beneficial Ownership, Deerfield Mgmt, Investment, SEC Filing, Common Stock, Passive Investment